Full-Time

GBM Private

Financing Group, Leveraged Finance, Natural Resources, Associate

Posted on 2/18/2025

Goldman Sachs

Goldman Sachs

Global investment banking and asset management firm

Fintech
Social Impact
Financial Services

Compensation Overview

$150k - $225kAnnually

+ Discretionary Bonus

Mid, Senior

Company Does Not Provide H1B Sponsorship

New York, NY, USA

Category
Investment Banking
Finance & Banking
Required Skills
Financial analysis
Risk Management
Investment Banking

You match the following Goldman Sachs's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • MBA or equivalent graduate degree in a financial discipline and 1 year of experience; OR
  • Bachelors degree PLUS minimum 3 years’ experience in an investment banking analyst position or comparable financial role
Responsibilities
  • Develop, structure and execute a broad range of advisory assignments and financial transactions for clients
  • Develop strong fundamental credit, modeling and risk management skills
Desired Qualifications
  • Exceptional communication skills, both verbal and written
  • Strong analytical orientation, with experience performing financial and valuation analysis in Excel or comparable spreadsheet tools
  • Demonstrated interest in finance, companies, transactions and financial markets

Goldman Sachs provides a variety of financial services, including investment banking, asset management, and securities trading. The firm offers advisory services for mergers and acquisitions, helps clients with underwriting securities, and manages assets for a diverse range of clients, including corporations, financial institutions, governments, and wealthy individuals. Revenue is earned through fees for these advisory services, trading commissions, and asset management fees. Goldman Sachs distinguishes itself from competitors by its extensive experience and commitment to social responsibility, which includes initiatives to support small businesses and promote racial equity. The company's goal is to deliver high-quality financial services while also making a positive impact on society.

Company Size

N/A

Company Stage

IPO

Total Funding

N/A

Headquarters

New York City, New York

Founded

1869

Simplify Jobs

Simplify's Take

What believers are saying

  • Goldman Sachs' investment in Float Financial captures the growing Canadian business finance market.
  • High demand for aerospace IPOs presents lucrative opportunities for Goldman Sachs.
  • Commitment to environmental projects enhances Goldman Sachs' reputation in social responsibility.

What critics are saying

  • Increased competition in AI-driven financial platforms may challenge Goldman Sachs' market share.
  • Rising digital nutritional therapy investments could divert focus from traditional financial services.
  • Strong investor interest in aerospace IPOs may divert capital from financial services.

What makes Goldman Sachs unique

  • Goldman Sachs invests in AI-driven platforms like 73 Strings for enhanced financial intelligence.
  • The firm supports urban infrastructure projects, aligning with its social responsibility goals.
  • Goldman Sachs is expanding into health-focused financial services with investments in companies like Fay.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Paid Vacation

Paid Sick Leave

Paid Holidays

Professional Development Budget

Company News

Business Wire
Feb 20th, 2025
73 Strings Secures $55m Series B Led by Growth Equity at Goldman Sachs Alternatives

73 Strings, the financial intelligence platform using AI to revolutionize data extraction, monitoring, and valuation for the $17.6 Trillion AUM Altern

Business Wire
Feb 15th, 2025
Sarepta Therapeutics Announces Inaugural $600 Million Senior Secured Revolving Credit Facility

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced today that it has closed on a $600 mil

Business Wire
Feb 14th, 2025
Newleos Therapeutics Debuts with $93.5 Million Oversubscribed Series A Financing to Transform the Treatment of Neuropsychiatric Disorders through the Advancement of Novel Medicines

Newleos Therapeutics, Inc., a clinical stage neuroscience company co-founded by Longwood Fund and seasoned leaders in CNS drug development, today anno

Tines
Feb 11th, 2025
Announcing our $125M Series C fundraise | Tines

Learn how we’re accelerating investments in product innovation, world-class support, value-adding AI features, and enhanced security capabilities.

Business Wire
Feb 6th, 2025
Fay Raises $50M Series B at a $500M Valuation to Revolutionize How We Think and Feel About Food

Fay, a leader in digital nutritional therapy, announced yesterday a $50 million Series B funding round led by Goldman Sachs at a $500 million valuatio